Загрузка...
Naturally occurring dominant resistance mutations to HCV protease and polymerase inhibitors in treatment-naïve patients
Resistance mutations to HCV NS3 protease inhibitors in <1% of the viral quasispecies may still allow >1000-fold viral load reductions upon treatment, consistent with their reported reduced replicative fitness in vitro. Recently, however, an R155K protease mutation was reported as the dominant...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Статья |
| Язык: | English |
| Опубликовано: |
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2645896/ https://ncbi.nlm.nih.gov/pubmed/19026009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.22549 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|